List view / Grid view

Dr Claire Foldi (Researcher at Monash University)

 

news

New psilocybin data highlights challenges for anorexia drug development

New preclinical research shows that psilocybin’s behavioural and inflammatory effects…

4 February 2026 | By

New preclinical research shows that psilocybin’s behavioural and inflammatory effects vary with metabolic state and exercise, highlighting key biological variables that could inform drug discovery, target selection and patient stratification in psychedelic therapeutics.